Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04HOT
|
|||
| Former ID |
DIB010449
|
|||
| Drug Name |
LFG-316
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Macular degeneration [ICD-11: 9B78.3; ICD-10: H35.3; ICD-9: 362.5] | Phase 2 | [1] | |
| Company |
Novartis AG
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01527500) Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD). U.S. National Institutes of Health. | |||
| REF 2 | Advances in the management of macular degeneration. F1000Prime Rep. 2014; 6: 29. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.